IL131041A0 - Compositions and methods for reducing ocular hypertension - Google Patents

Compositions and methods for reducing ocular hypertension

Info

Publication number: IL131041A0
Authority: IL; Israel
Prior art keywords: compositions; methods; ocular hypertension; reducing ocular; reducing
Prior art date: 1997-03-17

Application number

IL13104198A

Other languages

English (en)

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-17

Filing date

1998-03-13

Publication date

2001-01-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38729083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL131041(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-03-13 Application filed by Novartis Ag filed Critical Novartis Ag

2001-01-28 Publication of IL131041A0 publication Critical patent/IL131041A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

IL13104198A 1997-03-17 1998-03-13 Compositions and methods for reducing ocular hypertension IL131041A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81922197A	1997-03-17	1997-03-17
PCT/EP1998/001483 WO1998041208A1 (en)	1997-03-17	1998-03-13	Compositions and methods for reducing ocular hypertension

Publications (1)

Publication Number	Publication Date
IL131041A0 true IL131041A0 (en)	2001-01-28

Family

ID=38729083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13104198A IL131041A0 (en)	1997-03-17	1998-03-13	Compositions and methods for reducing ocular hypertension

Country Status (32)

Country	Link
EP (1)	EP0969846B2 (de)
JP (2)	JP4920124B2 (de)
KR (1)	KR100555818B1 (de)
CN (1)	CN1236775C (de)
AR (2)	AR002194A1 (de)
AT (1)	ATE257385T1 (de)
AU (1)	AU738781B2 (de)
BR (2)	BRPI9816218B1 (de)
CA (1)	CA2280089C (de)
CL (1)	CL2009001870A1 (de)
CO (1)	CO4940427A1 (de)
CY (1)	CY2526B1 (de)
CZ (1)	CZ299833B6 (de)
DE (1)	DE69820997T3 (de)
DK (1)	DK0969846T4 (de)
EE (1)	EE04091B1 (de)
ES (1)	ES2214706T5 (de)
HU (1)	HU228896B1 (de)
ID (1)	ID22389A (de)
IL (1)	IL131041A0 (de)
MY (1)	MY122237A (de)
NO (1)	NO327713B1 (de)
NZ (1)	NZ337322A (de)
PE (1)	PE61899A1 (de)
PL (1)	PL197509B1 (de)
PT (1)	PT969846E (de)
RU (1)	RU2197970C2 (de)
SI (1)	SI0969846T2 (de)
TW (1)	TW527187B (de)
UA (1)	UA63938C2 (de)
WO (1)	WO1998041208A1 (de)
ZA (1)	ZA982188B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6011062A (en) *	1994-12-22	2000-01-04	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
AR002194A1 (es) *	1997-03-17	1998-01-07	Sanchez Reynaldo Alemany	Instrumento computarizado para el analisis del movimiento.
US6187818B1 (en)	1998-06-17	2001-02-13	Pharmacia & Upjohn Company	Prostaglandins formulation and process
JP4880808B2 (ja) *	1999-11-15	2012-02-22	久光製薬株式会社	人工涙液型点眼剤組成物
JP4000505B2 (ja) *	1999-12-01	2007-10-31	第一三共株式会社	緑内障を治療するための併用剤
US20040097592A1 (en) *	2000-09-13	2004-05-20	Kenji Morishima	Eye drops
AU2002218527A1 (en) *	2000-12-05	2002-06-18	Sankyo Company Limited	Ocular tension-lowering compositions for topical administration
US20020198209A1 (en) *	2001-05-03	2002-12-26	Allergan Sales Inc.	Compositions having enhanced pharmacokinetic characteristics
US7074827B2 (en) *	2002-10-24	2006-07-11	Sucampo Ag (Usa) Inc.	Method for treating ocular hypertension and glaucoma
RU2266572C1 (ru) *	2004-03-17	2005-12-20	Российский государственный медицинский университет	Способ моделирования злокачественной артериальной гипертонии
TWI339659B (en) *	2004-03-18	2011-04-01	R Tech Ueno Ltd	Aqueous composition comprising thiazole derivative
US8569367B2 (en) *	2004-11-16	2013-10-29	Allergan, Inc.	Ophthalmic compositions and methods for treating eyes
GB0501192D0 (en) *	2005-01-20	2005-03-02	Resolution Chemicals Ltd	Stable prostaglandin-containing compositions
US7851504B2 (en) *	2005-03-16	2010-12-14	Allergan, Inc.	Enhanced bimatoprost ophthalmic solution
DE202005005094U1 (de) *	2005-03-31	2005-07-28	Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh	Ophthalmische Zusammensetzung
US8030349B2 (en) *	2005-08-02	2011-10-04	Santen Pharmaceutical Co., Ltd.	Method for prevention of degradation of thermally unstable medicament
JP5252787B2 (ja) *	2005-08-02	2013-07-31	参天製薬株式会社	熱的に不安定な薬物の分解抑制方法
JP2007099647A (ja) *	2005-09-30	2007-04-19	Kobayashi Pharmaceut Co Ltd	粘膜適用組成物
US8168206B1 (en)	2005-10-06	2012-05-01	Allergan, Inc.	Animal protein-free pharmaceutical compositions
CN104224704A (zh) *	2006-03-13	2014-12-24	株式会社·R-技术上野	水性组合物
BRPI0709549A2 (pt) *	2006-03-17	2011-07-19	Johnson & Johnson Vision Care	métodos para estabilizar composições instáveis oxidativamente
KR20090082401A (ko) *	2006-10-31	2009-07-30	알콘 리서치, 리미티드	안 질환 치료용 ｐａｉ－１ 결합 조절제
JPWO2008096804A1 (ja) *	2007-02-07	2010-05-27	テイカ製薬株式会社	ラタノプロスト含有点眼剤
JP2009073788A (ja) *	2007-09-21	2009-04-09	Teika Seiyaku Kk	イソプロピルウノプロストン含有眼用組成物
EA019867B1 (ru) *	2007-10-08	2014-06-30	Фовея Фармасьютикалс	Водные офтальмологические препараты
TWI544927B (zh)	2008-03-17	2016-08-11	愛爾康研究有限公司	具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
SI2254549T2 (sl) *	2008-03-17	2019-08-30	Alcon Research, Ltd.	Vodni farmacevtski sestavki, ki vsebujejo komplekse borata/poliola
EP2127638A1 (de)	2008-05-30	2009-12-02	Santen Pharmaceutical Co., Ltd	Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
RU2402316C2 (ru) *	2009-01-11	2010-10-27	Пшеничников Виталий Георгиевич	Фармацевтическая антиглаукомная композиция
US8952051B2 (en) *	2009-11-05	2015-02-10	Allergan, Inc.	Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
EP2696876A4 (de) *	2011-04-12	2014-09-03	R Tech Ueno Ltd	Wässrige ophthalmische zusammensetzung
US20130029919A1 (en) *	2011-07-26	2013-01-31	Allergan, Inc.	Two part formulation system for opthalmic delivery
EP2567689A1 (de)	2011-09-12	2013-03-13	Visiotact Pharma	Ophthalmische Zusammensetzungen enhaltend Prostaglandin-F2-alpha-Derivate und Hyaluronsäure
US8957048B2 (en)	2011-10-06	2015-02-17	Allergan, Inc.	Compositions for the treatment of dry eye
RU2014127074A (ru)	2011-12-07	2016-02-10	Аллерган, Инк.	Состав для эффективной доставки липидов в слезную пленку человека с использованием чувствительной к соли эмульсионной системы
US9907826B2 (en)	2011-12-07	2018-03-06	Allergan, Inc.	Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP3223794A1 (de)	2014-11-25	2017-10-04	Allergan, Inc.	Stabilisierte ophthalmische omega-3-zusammensetzungen
JP7520851B2 (ja) *	2018-09-21	2024-07-23	アウフバウ・メディカル・イノベイションズ・リミテッド	緑内障用の組成物および方法
CA3136356A1 (en)	2019-04-12	2020-10-15	Ecolab Usa Inc.	Antimicrobial multi-purpose cleaner and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2042936C (en) *	1990-05-22	2002-04-30	Ryuji Ueno	Treatment of ocular hypertension with a synergistic combination for ophthalmic use
US5767154A (en) *	1991-02-07	1998-06-16	Allergan	5-trans-prostaglandins of the F series and their use as ocular hypotensives
WO1992013836A1 (en) *	1991-02-07	1992-08-20	Allergan, Inc.	2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f derivatives
CA2166722A1 (en) *	1994-05-06	1995-11-16	Manoj L. Maniar	Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5631287A (en) †	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
US5558876A (en) *	1995-03-29	1996-09-24	Alcon Laboratories, Inc.	Topical ophthalmic acidic drug formulations
AR002194A1 (es) *	1997-03-17	1998-01-07	Sanchez Reynaldo Alemany	Instrumento computarizado para el analisis del movimiento.

1996
- 1996-06-03 AR ARP960102868A patent/AR002194A1/es unknown
1998
- 1998-03-09 MY MYPI98001017A patent/MY122237A/en unknown
- 1998-03-13 SI SI9830616T patent/SI0969846T2/sl unknown
- 1998-03-13 JP JP54012698A patent/JP4920124B2/ja not_active Expired - Lifetime
- 1998-03-13 DE DE69820997T patent/DE69820997T3/de not_active Expired - Lifetime
- 1998-03-13 ES ES98916948T patent/ES2214706T5/es not_active Expired - Lifetime
- 1998-03-13 CN CNB988030195A patent/CN1236775C/zh not_active Expired - Fee Related
- 1998-03-13 EE EEP199900410A patent/EE04091B1/xx not_active IP Right Cessation
- 1998-03-13 DK DK98916948.7T patent/DK0969846T4/da active
- 1998-03-13 WO PCT/EP1998/001483 patent/WO1998041208A1/en not_active Ceased
- 1998-03-13 AU AU70353/98A patent/AU738781B2/en not_active Ceased
- 1998-03-13 CO CO98014184A patent/CO4940427A1/es unknown
- 1998-03-13 RU RU99121641/14A patent/RU2197970C2/ru not_active IP Right Cessation
- 1998-03-13 AT AT98916948T patent/ATE257385T1/de active
- 1998-03-13 BR BRPI9816218A patent/BRPI9816218B1/pt not_active IP Right Cessation
- 1998-03-13 EP EP98916948A patent/EP0969846B2/de not_active Expired - Lifetime
- 1998-03-13 HU HU0002194A patent/HU228896B1/hu not_active IP Right Cessation
- 1998-03-13 KR KR1019997008431A patent/KR100555818B1/ko not_active Expired - Fee Related
- 1998-03-13 IL IL13104198A patent/IL131041A0/xx not_active IP Right Cessation
- 1998-03-13 CZ CZ0325799A patent/CZ299833B6/cs not_active IP Right Cessation
- 1998-03-13 PE PE1998000177A patent/PE61899A1/es not_active Application Discontinuation
- 1998-03-13 PL PL335168A patent/PL197509B1/pl unknown
- 1998-03-13 UA UA99095110A patent/UA63938C2/uk unknown
- 1998-03-13 BR BR9808016-4A patent/BR9808016A/pt not_active Application Discontinuation
- 1998-03-13 ID IDW991029A patent/ID22389A/id unknown
- 1998-03-13 AR ARP980101150A patent/AR011192A1/es not_active Application Discontinuation
- 1998-03-13 NZ NZ337322A patent/NZ337322A/en not_active IP Right Cessation
- 1998-03-13 PT PT98916948T patent/PT969846E/pt unknown
- 1998-03-13 CA CA002280089A patent/CA2280089C/en not_active Expired - Fee Related
- 1998-03-16 ZA ZA982188A patent/ZA982188B/xx unknown
- 1998-03-16 TW TW087103809A patent/TW527187B/zh not_active IP Right Cessation
1999
- 1999-09-16 NO NO19994481A patent/NO327713B1/no not_active IP Right Cessation
2005
- 2005-05-26 CY CY0500033A patent/CY2526B1/xx unknown
2009
- 2009-09-16 CL CL2009001870A patent/CL2009001870A1/es unknown
- 2009-10-09 JP JP2009235214A patent/JP2010043110A/ja active Pending

Also Published As

Publication number	Publication date
AU738781B2 (en)	2001-09-27
CZ325799A3 (cs)	2000-01-12
DE69820997T2 (de)	2004-12-09
HUP0002194A3 (en)	2012-08-28
EP0969846A1 (de)	2000-01-12
CA2280089C (en)	2009-03-03
DE69820997D1 (de)	2004-02-12
JP2001515502A (ja)	2001-09-18
SI0969846T2 (sl)	2010-12-31
AR011192A1 (es)	2000-08-02
NO994481D0 (no)	1999-09-16
AR002194A1 (es)	1998-01-07
EP0969846B2 (de)	2010-08-25
CZ299833B6 (cs)	2008-12-10
WO1998041208A1 (en)	1998-09-24
BR9808016A (pt)	2000-03-08
ZA982188B (en)	1998-09-17
MY122237A (en)	2006-04-29
ES2214706T5 (es)	2011-02-02
CA2280089A1 (en)	1998-09-24
SI0969846T1 (en)	2004-06-30
EP0969846B1 (de)	2004-01-07
HU228896B1 (en)	2013-06-28
NO994481L (no)	1999-09-16
PL335168A1 (en)	2000-04-10
CN1249687A (zh)	2000-04-05
DE69820997T3 (de)	2011-10-06
EE9900410A (et)	2000-04-17
TW527187B (en)	2003-04-11
PL197509B1 (pl)	2008-04-30
KR100555818B1 (ko)	2006-03-03
CL2009001870A1 (es)	2010-01-22
ATE257385T1 (de)	2004-01-15
BRPI9816218B1 (pt)	2016-04-12
ES2214706T3 (es)	2004-09-16
PE61899A1 (es)	1999-06-30
CN1236775C (zh)	2006-01-18
NZ337322A (en)	2001-05-25
NO327713B1 (no)	2009-09-14
KR20000076330A (ko)	2000-12-26
DK0969846T3 (da)	2004-04-13
PT969846E (pt)	2004-05-31
CO4940427A1 (es)	2000-07-24
DK0969846T4 (da)	2010-12-20
ID22389A (id)	1999-10-07
CY2526B1 (en)	2006-02-08
JP2010043110A (ja)	2010-02-25
JP4920124B2 (ja)	2012-04-18
AU7035398A (en)	1998-10-12
HK1026841A1 (en)	2000-12-29
RU2197970C2 (ru)	2003-02-10
UA63938C2 (uk)	2004-02-16
HUP0002194A2 (hu)	2000-12-28
EE04091B1 (et)	2003-08-15

Publication	Publication Date	Title
IL131041A0 (en)	2001-01-28	Compositions and methods for reducing ocular hypertension
AU3767097A (en)	1998-02-25	Shampoo compositions and method
ZA958028B (en)	1996-04-18	Compositions and methods for treatig mast-cell mediated conditions
AU8693098A (en)	1999-03-01	Compositions and methods for treating diabetes
AU9214398A (en)	1999-05-31	Compositions and methods for treating water
ZA989399B (en)	1999-04-15	Method and composition
HUP0004234A3 (en)	2001-08-28	Dolastatin 15 derivatives
AU2349399A (en)	1999-08-16	R-lansoprazole compositions and methods
ZA989398B (en)	1999-04-15	Method and composition (l)
AU7685798A (en)	1998-12-30	Compositions and methods for preventing adhesion
AU2664797A (en)	1997-11-07	Wnt receptor compositions and methods
GB9624501D0 (en)	1997-01-15	Insecticial compositions and method
AUPO982097A0 (en)	1997-11-06	Methods and compositions for use therein
AU5342498A (en)	1998-08-03	Difluprednate-containing ophthalmic o/w emulsion composition
AU9393798A (en)	1999-04-05	Genetic compositions and methods
AU5546298A (en)	1998-08-03	Methods and compositions for preventing autoimmune disease
AU3900499A (en)	1999-12-06	(+)-hydroxyrisperidone compositions and methods
AU7287798A (en)	1998-11-27	Compositions and methods for bioremediation
AU7799898A (en)	1998-12-30	Compositions and methods for treating glaucoma
AU9105498A (en)	1999-03-08	Novel compositions and methods for controlling nematodes
AU9474898A (en)	1999-04-05	Methods and compositions for diagnosing and treating malaria
GB9719842D0 (en)	1997-11-19	Ophthalmic compositions for treating ocular hypertension
GB9717153D0 (en)	1997-10-22	Eyedrop composition
GB9721425D0 (en)	1997-12-10	Composition and method
GB9704297D0 (en)	1997-04-23	Composition and method

Legal Events

Date	Code	Title
2005-09-25	KB	Patent renewed
2008-04-13	KB	Patent renewed
2012-03-29	KB	Patent renewed
2016-10-31	MM9K	Patent not in force due to non-payment of renewal fees